Mayo Clinic Partners With Nvidia to Launch AI Platform for Precision Medicine

Mayo Clinic's Atlas pathology foundation model, developed with biomedical AI company Aignostics, has been trained on a dataset of more than 1.2 million histopathology whole-slide images.

Mayo Clinic has partnered with Nvidia to introduce an AI computing platform to advance digital pathology, drug discovery, and precision medicine.

The Rochester, Minnesota-based health system said the initiative is part of its “Bold. Forward. Unbound.” strategy to integrate AI solutions into clinical care.

The deployment of Nvidia’s DGX SuperPOD powered by DGX B200 systems will provide the computing infrastructure for developing foundation models in key areas such as pathomics.

According to Mayo Clinic, the system’s advanced capabilities are expected to reduce the time needed to analyze pathology slides from four weeks to one.

The Nvidia Blackwell-powered SuperPOD is optimized for high-resolution imaging and will support the creation of generative AI tools in healthcare. Mayo Clinic's Atlas pathology foundation model, developed with biomedical AI company Aignostics, has been trained on a dataset of more than 1.2 million histopathology whole-slide images.

The model is already in use by clinicians and researchers to enhance diagnostic accuracy.

Stay tuned for more such updates on Digital Health News